Tuesday - April 14, 2026

Category Archives: Pharmaceuticals & Biotech

Hepatocellular Carcinoma Clinical Trial Pipeline Expands as 90+ Companies Driving Innovation in the Therapeutics | DelveInsight

DelveInsight’s “Hepatocellular Carcinoma Pipeline Insight 2026 report provides comprehensive insights about 90+ companies and 95+ pipeline drugs in the Hepatocellular Carcinoma pipeline landscape. It covers the Hepatocellular Carcinoma pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading →

Diabetic Macular Edema Clinical Trial Pipeline Shows Potential with Active Contributions from 45+ Key Companies | DelveInsight

DelveInsight’s “Diabetic Macular Edema Pipeline Insight 2026” report provides comprehensive insights about 45+ companies and 50+ pipeline drugs in Diabetic Macular Edema pipeline landscape. It covers the Diabetic Macular Edema pipeline drug profiles, including clinical and nonclinical stage products. It … Continue reading →

Diffuse Large B-Cell Lymphoma Clinical Trial Pipeline Gains Momentum: 70+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s, “Diffuse Large B-Cell Lymphoma Pipeline Insights 2026” report provides comprehensive insights about 70+ companies and 75+ pipeline drugs in Diffuse Large B-Cell Lymphoma pipeline landscape. It covers the Diffuse Large B-Cell Lymphoma pipeline drug profiles, including clinical and nonclinical … Continue reading →

HER2-Negative Breast Cancer Clinical Trial Pipeline Accelerates as 70+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s “HER2-Negative Breast Cancer Pipeline Insight 2026” report provides comprehensive insights about 70+ companies and 75+ pipeline drugs in HER2-Negative Breast Cancer pipeline landscape. It covers the HER2-Negative Breast Cancer pipeline drug profiles, including clinical and nonclinical stage products. It … Continue reading →

Type 2 Diabetes Clinical Trial Pipeline Expands as 75+ Pharma Companies Progress Novel Therapies Toward Market Entry, Finds DelveInsight | AstraZeneca, Eli Lilly, Tonghua Dongbao, Sciwind Biosciences

Type 2 Diabetes – Pipeline Insight, 2026 There are 75+ key companies, such as Tonghua Dongbao Pharmaceutical, Eli Lilly and Company, Rivus Pharmaceuticals, Celon Pharma, Sciwind Biosciences, AstraZeneca, Suzhou Alphamab Co., Ltd., Neurodon, Abarceo Pharma, Chong Kun Dang Pharmaceutical, and … Continue reading →

Cardiac Monitoring Devices Market Set for Sustained Growth at 5.17% CAGR Through 2034: DelveInsight | Philips, Medtronic, and Boston Scientific

Cardiac Monitoring Devices Market Insights The leading companies operating in the cardiac monitoring devices market include Koninklijke Philips N.V., Boston Scientific Corporation, Medtronic, Neurosoft, ACS Diagnostics, Abbott, Biotronik, GE Healthcare, AliveCor Inc., ZOLL Medical Corporation, Bexen Cardio, iRhythm Technologies, Inc., … Continue reading →

Wound Healing Devices Market Set for Sustained Growth at 5.07% CAGR Through 2032: DelveInsight | Smith & Nephew, ConvaTec, and Mölnlycke Health Care

Wound Healing Devices Market Insights Key global players include Smith & Nephew plc., BSN Medical, Cardinal Health, Organogenesis Inc., Coloplast Group, Integra LifeSciences Corporation, Acelity L.P., Inc., B. Braun Melsungen AG, Hollister Incorporated, Mölnlycke Health Care AB, 3M Healthcare, Medline … Continue reading →

BRAF Mutated Non-small Cell Lung Cancer Market: Rapid Increment Driven by Innovation by 2036 – DelveInsight | AbbVie, Xcovery, Sanofi, NeoImmune Tech, Merck KGaA and Pfizer, Mirati Therapeutics

The Key BRAF Mutated Non-small Cell Lung Cancer Companies in the marrket include – AbbVie, Xcovery, Sanofi, NeoImmune Tech, Merck KGaA and Pfizer, Mirati Therapeutics, AstraZeneca, Daiichi Sankyo, Inc., Gilead Sciences, Merck Sharp & Dohme LLC, Arcus Biosciences, Inc., Ono … Continue reading →

Peraso (NASDAQ: PRSO) Delivers Military Drone IFF Systems, Stock Sets Up for Potential Re-Coil

Peraso Inc. (NASDAQ: PRSO) announced it has delivered an initial limited production shipment of its 60GHz mmWave modules to Israeli defense contractor InTACT, marking a key milestone as the company advances from development into early-stage commercialization of its drone Identification … Continue reading →